Sort
15,842 grants matching “pancreatic cancer”
Epigenetic markers involved in colorectal cancer recurrence and metastases
$140,940Nita Ahuja · Johns Hopkins University · K23 · FY2011 · CA
Epigenetic markers involved in colorectal cancer recurrence and metastases
$140,940Nita Ahuja · Johns Hopkins University · K23 · FY2012 · CA
Epigenetic markers involved in colorectal cancer recurrence and metastases
$140,940Nita Ahuja · Johns Hopkins University · K23 · FY2009 · CA
Epigenetic markers involved in colorectal cancer recurrence and metastases
$140,940Nita Ahuja · Johns Hopkins University · K23 · FY2010 · CA
Epigenetic markers involved in colorectal cancer recurrence and metastases
$140,940Nita Ahuja · Johns Hopkins University · K23 · FY2008 · CA
Biospecimens and Patient-derived xenografts
$140,893David Marc Weinstock · Massachusetts Institute Of Technology · U54 · FY2019 · CA
The paradoxical roles of beta hydroxy butyrate in the liver pro-metastatic niche
$140,891Shelly Chi-Loo Lu · Cedars-Sinai Medical Center · P01 · FY2023 · CA
Project 1- Role of fat in metastatic engraftment and expansion in the liver
$140,891Neil A Bhowmick · Cedars-Sinai Medical Center · P01 · FY2023 · CA
REGULATION OF SMC/RMUC4 TRANSCRIPTION BY CELL SIGNALING
$140,809University Of Miami School Of Medicine · K01 · FY2004 · CA
Targeted Nanotherapy for Pancreatic Cancer
$140,790Subhash C. Chauhan · University Of Tennessee Health Sci Ctr · R01 · FY2019 · CA
Role of Interleukin-22 and Innate Lymphoid Cells in Pancreas Cancer Initiation and Progression
$140,655Timothy Louis Frankel · University Of Michigan At Ann Arbor · K08 · FY2019 · CA
Role of Interleukin-22 and Innate Lymphoid Cells in Pancreas Cancer Initiation and Progression
$140,655Timothy Louis Frankel · University Of Michigan At Ann Arbor · K08 · FY2020 · CA
Role of Interleukin-22 and Innate Lymphoid Cells in Pancreas Cancer Initiation and Progression
$140,655Timothy Louis Frankel · University Of Michigan At Ann Arbor · K08 · FY2018 · CA
Genomic Instability and The Roles of P53 and P19arf in Pancreatic Cancer
$140,620Aram F Hezel · Massachusetts General Hospital · K08 · FY2006 · CA
Bioinformatics, Statistical and Methodological Core
$140,456Enrique Israel Velazquez Villarreal · University Of Southern California · U54 · FY2020 · CA
Biological Models, Molecular Pathology and Biostatistics
$140,448Guillermo J. Tearney · Massachusetts General Hospital · P01 · FY2011 · CA
Coded-aperture Compton scatter imaging for real-time tumor motion tracking during ablative radiotherapy
$140,148Bernard L Jones · University Of Colorado Denver · R21 · FY2022 · CA
TARGETS OF METASTATIC PANCREATIC CANCER
$140,130Christine A Iacobuzio-Donahue · Johns Hopkins University · K08 · FY2006 · CA
TARGETS OF METASTATIC PANCREATIC CANCER
$140,130Johns Hopkins University · K08 · FY2005 · CA
Development of Novel Markers for Melanoma Progression
$140,130Byungwoo Ryu · Johns Hopkins University · K01 · FY2006 · CA
TARGETS OF METASTATIC PANCREATIC CANCER
$140,130Johns Hopkins University · K08 · FY2004 · CA
TARGETS OF METASTATIC PANCREATIC CANCER
$140,130Christine A Iacobuzio-Donahue · Johns Hopkins University · K08 · FY2008 · CA
TARGETS OF METASTATIC PANCREATIC CANCER
$140,130Christine A Iacobuzio-Donahue · Johns Hopkins University · K08 · FY2007 · CA
Mechanisms of Dicumarol-Induced Cytotoxicity
$140,125Joseph J Cullen · University Of Iowa · R21 · FY2006 · CA
P-2: Inhibitors of N-cahedrin in the treatment of pancreatic cancer
$140,122Keith R Johnson · University Of Nebraska Medical Center · P50 · FY2008 · CA